Viewing StudyNCT02960230



Ignite Creation Date: 2024-05-06 @ 9:23 AM
Last Modification Date: 2024-10-26 @ 12:13 PM
Study NCT ID: NCT02960230
Status: COMPLETED
Last Update Posted: 2024-02-22
First Post: 2016-11-02

Brief Title: H33K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
Sponsor: Sabine Mueller MD PhD
Organization: University of California San Francisco

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-11-18
Start Date Type: ACTUAL
Primary Completion Date: 2023-12-31
Primary Completion Date Type: ACTUAL
Completion Date: 2023-12-31
Completion Date Type: ACTUAL
First Submit Date: 2016-11-02
First Submit QC Date: November 8 2016
Study First Post Date: 2016-11-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-20
Last Update Post Date: 2024-02-22
Last Update Post Date Type: ACTUAL